Cotargeting survival signaling pathways in cancer.

The Journal of Clinical Investigation
Steven Grant

Abstract

Mammalian target of rapamycin (mTOR) is a component of a signaling pathway (PTEN/PI3K/AKT) that is frequently dysregulated in cancer. However, its precise relationship to the MAPK cascade (Ras/Raf/MEK/ERK), another pathway often implicated in tumorigenesis, has not been well defined. Recent evidence from tissue specimens obtained from patients who have received mTOR inhibitors suggests that ERK may be activated in response to mTOR interruption. In this issue of the JCI, Waugh Kinkade et al. and Carracedo et al. examine the relationship between these pathways in prostate and breast cancer cell model systems (see the related articles beginning on pages 3051 and 3065, respectively). Their findings suggest a link between inhibition of mTOR and ERK activation, possibly reflecting interruption of a novel negative S6K1-dependent feedback loop. Significantly, both groups observed that simultaneous inhibition of MEK/ERK and mTOR resulted in substantially enhanced antitumor effects both in vitro and in vivo. Together, these findings suggest that concurrent interruption of complementary signaling pathways warrants further investigation in cancer therapy.

References

Apr 14, 1999·Proceedings of the National Academy of Sciences of the United States of America·L C Cantley, B G Neel
Dec 2, 1999·Genes & Development·S R DattaM E Greenberg
May 4, 2004·Nature Reviews. Cancer·Mary-Ann Bjornsti, Peter J Houghton
Dec 2, 2004·Nature Reviews. Cancer·Judith S Sebolt-Leopold, Roman Herrera
Nov 12, 2005·The Journal of Biological Chemistry·Xiao-Jun QiPhilip H Howe
Feb 3, 2006·Cancer Research·Kathryn E O'ReillyNeal Rosen
Apr 11, 2006·Molecular Cell·Dos D SarbassovDavid M Sabatini
Jul 21, 2006·Advances in Enzyme Regulation·James A McCubreyMassimo Libra
Aug 9, 2006·Nature Clinical Practice. Oncology·I Bernard Weinstein, Andrew K Joe
Mar 14, 2007·The Journal of Experimental Medicine·Richard A Van Etten
Jul 3, 2007·Cell·Brendan D Manning, Lewis C Cantley
Jul 20, 2007·Cancer Research·Michael M Shen, Cory Abate-Shen
Nov 2, 2007·Nature Reviews. Cancer·Robin MathewEileen White
Nov 17, 2007·BioEssays : News and Reviews in Molecular, Cellular and Developmental Biology·Mari KaarbøFahri Saatcioglu
Aug 30, 2008·The Journal of Clinical Investigation·Arkaitz CarracedoPier Paolo Pandolfi
Aug 30, 2008·The Journal of Clinical Investigation·Carolyn Waugh KinkadeCory Abate-Shen

❮ Previous
Next ❯

Citations

Mar 18, 2009·The Journal of Biological Chemistry·Megumi Funakoshi-TagoTadashi Kasahara
Mar 29, 2012·Advances in Urology·Marco A De Velasco, Hirotsugu Uemura
Oct 29, 2009·Cancer Research·Nagarajarao ShamaladeviBal L Lokeshwar
Sep 10, 2011·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Rong WuKathleen R Cho
Nov 18, 2011·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Hiu-Fung YuenMohamed El-Tanani
Apr 17, 2012·PloS One·Shih-Wei WangChih-Hsin Tang
Feb 4, 2012·Journal of Agricultural and Food Chemistry·Harini S AiyerRobert Clarke
Jul 4, 2012·Journal of Cancer Research and Clinical Oncology·Ilina K DinevaMartin R Berger
Apr 16, 2013·Journal of Cardiac Failure·Brent A McLeanGavin Y Oudit
May 3, 2012·Journal of Controlled Release : Official Journal of the Controlled Release Society·Ho-Chul ShinGlen S Kwon
Dec 27, 2011·Human Pathology·Atif A AhmedBruce R Pawel
Apr 2, 2011·Biochemical Pharmacology·Chun-Han HouChih-Hsin Tang
Mar 24, 2010·Biochemical and Biophysical Research Communications·Jae-Sun ChoiJoo-Won Jeong
Jan 5, 2010·Steroids·T S Karin Eisinger-MathasonDeborah A Lannigan
Dec 5, 2009·Best Practice & Research. Clinical Haematology·Steven Grant
Jun 9, 2009·Toxicology in Vitro : an International Journal Published in Association with BIBRA·D JyothiA S Sreedhar
Jul 18, 2009·Biochemical and Biophysical Research Communications·Ju-Hwa KimSungpil Yoon
Apr 28, 2009·Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy·Paul DentSteven Grant
Mar 31, 2009·International Immunopharmacology·Miyuki AbeTadashi Kasahara
Feb 12, 2009·The Journal of Investigative Dermatology·Richard A F Clark, Michelle Pavlis
Sep 3, 2009·Journal of Cellular Biochemistry·Uma Kant Misra, Salvatore Vincent Pizzo
Jun 29, 2011·International Journal of Cancer. Journal International Du Cancer·Arti ShuklaBrooke T Mossman
Jun 1, 2010·Molecular Carcinogenesis·Xian-Guo ChenQian-Yuan Zhuang
Jun 5, 2014·Phytotherapy Research : PTR·Jong-Ho ChoYoung-Sam Keum
Oct 12, 2013·The Prostate·Shyh-Han TanShiv Srivastava
Nov 3, 2011·Journal of Signal Transduction·Gonzalo Rodríguez-BerrigueteMar Royuela
Jul 13, 2013·International Immunopharmacology·Mingjin YangYoufan Jiang
Aug 1, 2015·Blood Cells, Molecules & Diseases·Kamil BojarczukMagdalena Winiarska
Apr 4, 2015·Experimental Cell Research·Naomasa IshidaYoshio Naomoto
May 7, 2013·Cancer Treatment Reviews·Kamal S SainiMartine J Piccart-Gebhart

❮ Previous
Next ❯

Methods Mentioned

BETA
transgenic
biopsies

Related Concepts

Related Feeds

AKT Pathway

This feed focuses on the AKT serine/threonine kinase, which is an important signaling pathway involved in processes such as glucose metabolism and cell survival.